Unum's stock declined 1.3% following the quarter, reflecting investor caution despite stable sales and returns, weighed down by elevated claims experience in U.S. paid family and medical leave and weaker-than-expected U.K. group business results.
- Continued underlying premium growth of roughly 5% supported by solid persistency and successful new customer acquisition.
- U.S. Unum sales increased 7.4% for the quarter, with year-to-date sales growth of 14%, driven by digital connectivity and leave management capabilities.
- Colonial Life achieved 6% sales growth and attractive returns near 20%, benefiting from disciplined execution and market positioning.
- Elevated claims experience pressured U.S. group disability short-term disability results, primarily due to emerging paid family and medical leave markets.
- U.K. group business results fell short of expectations, with elevated claims and targeted pricing actions underway to restore attractive returns.
Community Discussion